Over The Counter (OTC) Drugs Global Market Opportunities And Strategies To 2034

Published Jun 20, 2025

Length 373 Pages

SKU # BRC20121409

Description

Over The Counter (OTC) Drugs Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global over the counter (OTC) drugs market as it emerges from the COVID-19 shut down.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Description:

Where is the largest and fastest-growing market for over the counter (OTC) drugs? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The over the counter (OTC) drugs market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider over the counter (OTC) drugs market; and compares it with other markets.

The report covers the following chapters

Introduction And Market Characteristics:- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type, by formulation type, by distribution channel and by end user.
Key Trends:- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
Growth Analysis And Strategic Analysis:- Framework Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
Regional And Country Analysis:- Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
Market Segmentation:- Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by type, by formulation type, by distribution channel and by end user in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
Regional Market Size And Growth:- Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Competitive Landscape:- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
Other Major And Innovative Companies:- Details on the company profiles of other major and innovative companies in the market.
Competitive Benchmarking:- Briefs on the financials comparison between major players in the market.
Competitive Dashboard:- Briefs on competitive dashboard of major players.
Key Mergers And Acquisitions:- Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
Recent Developments:- Information on recent developments in the market covered in the report.
Market Opportunities And Strategies:- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets
Conclusions And Recommendations:- This section includes recommendations for over-the-counter (OTC) drugs market providers in terms of product/service offerings geographic expansion, marketing strategies and target groups
Appendix:- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

1) By Type: Cough, Cold And Flu Products; Analgesics; Dermatology Products; Gastrointestinal Products; Vitamins, Mineral And Supplements (VMS); Weight Loss Or Dietary Products; Ophthalmic Products; Sleeping Aids; Other Product Types

2) By Formulation Type: Tablets; Liquids; Ointments; Sprays; Other Formulation Types

3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Channels

4) By End User: Specialty Clinics; Homecare; Hospitals; Other End Users

Companies Mentioned: Bayer AG; Johnson & Johnson; GlaxoSmithKline PLC; Reckitt Benckiser Group PLC; Sanofi S.A.

Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time-series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; over the counter (OTC) drugs indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

1 Executive Summary: 1.1.1 Over The Counter (OTC) Drugs – Market Attractiveness And Macro Economic Landscape
2 Table Of Contents
3 List Of Tables
4 List Of Figures
5 Report Structure
6 Market Characteristics: 6.1 General Market Definition; 6.2 Summary; 6.3 Over The Counter (OTC) Drugs Market Definition And Segmentations; 6.4 Market Segmentation By Type; 6.4.1 Cough, Cold and Flu Products; 6.4.2 Analgesics; 6.4.3 Dermatology Products; 6.4.4 Gastrointestinal Products; 6.4.5 Vitamins, Minerals and Supplements (VMS); 6.4.6 Weight Loss or Dietary Products; 6.4.7 Ophthalmic Products; 6.4.8 Sleeping Aids; 6.4.9 Other Product Types; 6.5 Market Segmentation By Formulation Type; 6.5.1 Tablets; 6.5.2 Liquids; 6.5.3 Ointments; 6.5.4 Sprays; 6.5.5 Other Formulation Types; 6.6 Market Segmentation By Distribution Channel; 6.6.1 Hospital Pharmacies; 6.6.2 Retail Pharmacies; 6.6.3 Online Pharmacies; 6.6.4 Other Channels; 6.7 Market Segmentation By End User; 6.7.1 Specialty Clinics; 6.7.2 Homecare; 6.7.3 Hospitals; 6.7.4 Other End Users
7 Major Market Trends: 7.1 Development of Bioequivalent Ophthalmic Solution to Provide Eye Allergy Relief; 7.2 Innovative Fast-Acting OTC Gels For Erectile Dysfunction Treatment; 7.3 Launch of Affordable Nasal Spray to Combat Opioid Overdoses; 7.4 Groundbreaking Over-the-Counter Birth Control Pill Offers Greater Access; 7.5 Innovative OTC Drugs Targeting Diarrhea From Overeating And Overdrinking
8 Over The Counter (OTC) Drugs Growth Analysis And Strategic Analysis Framework: 8.1 Global Over The Counter (OTC) Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors); 8.1.1 Political; 8.1.2 Economic; 8.1.3 Social; 8.1.4 Technological; 8.1.5 Environmental; 8.1.6 Legal; 8.2 Analysis Of End User (B2B); 8.2.1 Specialty Clinics; 8.2.2 Homecare; 8.2.3 Hospitals; 8.2.4 Other End Users; 8.3 Over The Counter (OTC) Drugs Market Growth Rate Analysis; 8.4 Historic Market Growth, 2019 – 2024, Value ($ Million); 8.4.1 Market Drivers 2019 – 2024; 8.4.2 Market Restraints 2019– 2024; 8.5 Forecast Market Growth, 2024 – 2029, 2034F Value ($ Million); 8.5.1 Market Drivers 2024 – 2029; 8.5.2 Market Restraints 2024 – 2029; 8.6 Forecast Growth Contributors/Factors; 8.6.1 Quantitative Growth Contributors; 8.6.2 Drivers; 8.6.3 Restraints; 8.7 Over The Counter (OTC) Drugs Total Addressable Market (TAM)
9 Over The Counter (OTC) Drugs Market Segmentation: 9.1 Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 9.2 Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 9.3 Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 9.4 Over The Counter (OTC) Drugs Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 9.5 Over The Counter (OTC) Drugs Market, Sub-Segmentation By Cough, Cold, And Flu Products, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 9.6 Over The Counter (OTC) Drugs Market, Sub-Segmentation By Analgesics, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 9.7 Over The Counter (OTC) Drugs Market, Sub-Segmentation Of Dermatology Products, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 9.8 Over The Counter (OTC) Drugs Market, Sub-Segmentation By Gastrointestinal Products, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 9.9 Over The Counter (OTC) Drugs Market, Sub-Segmentation By Vitamins, Mineral, And Supplements (VMS), By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 9.10 Over The Counter (OTC) Drugs Market, Sub-Segmentation By Weight Loss Or Dietary Products, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 9.11 Over The Counter (OTC) Drugs Market, Sub-Segmentation By Ophthalmic Products, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 9.12 Over The Counter (OTC) Drugs Market, Sub-Segmentation By Sleeping Aids, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 9.13 Over The Counter (OTC) Drugs Market, Sub-Segmentation By Other Product Types, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
10 Over The Counter (OTC) Drugs Market, Regional and Country Analysis: 10.1 Over The Counter (OTC) Drugs Market, By Region, Historic and Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 10.2 Over The Counter (OTC) Drugs Market, By Country, Historic and Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11 Asia-Pacific Market: 11.1 Summary; 11.2 Market Overview; 11.2.1 Region Information; 11.2.2 Market Information; 11.2.3 Background Information; 11.2.4 Government Initiatives; 11.2.5 Regulations; 11.2.6 Regulatory Bodies; 11.2.7 Major Associations; 11.2.8 Taxes Levied; 11.2.9 Corporate Tax Structure; 11.2.10 Investments; 11.2.11 Major Companies; 11.3 Asia-Pacific Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.4 Asia-Pacific Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.5 Asia-Pacific Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.6 Asia-Pacific Over The Counter (OTC) Drugs Market: Country Analysis; 11.7 China Market; 11.8 Summary; 11.9 Market Overview; 11.9.1 Country Information; 11.9.2 Market Information; 11.9.3 Background Information; 11.9.4 Government Initiatives; 11.9.5 Regulations; 11.9.6 Regulatory Bodies; 11.9.7 Major Associations; 11.9.8 Taxes Levied; 11.9.9 Corporate Tax Structure; 11.9.10 Investments; 11.9.11 Major Companies; 11.10 China Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.11 China Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.12 China Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.13 India Market; 11.14 India Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.15 India Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.16 India Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.17 Japan Market; 11.18 Summary; 11.19 Market Overview; 11.19.1 Country Information; 11.19.2 Market Information; 11.19.3 Background Information; 11.19.4 Government Initiatives; 11.19.5 Regulations; 11.19.6 Regulatory Bodies; 11.19.7 Major Associations; 11.19.8 Taxes Levied; 11.19.9 Corporate Tax Structure; 11.19.10 Investments; 11.19.11 Major Companies; 11.20 Japan Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.21 Japan Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.22 Japan Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.23 Australia Market; 11.24 Australia Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.25 Australia Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.26 Australia Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.27 Indonesia Market; 11.28 Indonesia Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.29 Indonesia Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.30 Indonesia Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.31 South Korea Market; 11.32 Summary; 11.33 Market Overview; 11.33.1 Country Information; 11.33.2 Market Information; 11.33.3 Background Information; 11.33.4 Government Initiatives; 11.33.5 Regulations; 11.33.6 Regulatory Bodies; 11.33.7 Major Associations; 11.33.8 Taxes Levied; 11.33.9 Corporate Tax Structure; 11.33.10 Investments; 11.33.11 Major Companies; 11.34 South Korea Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.35 South Korea Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.36 South Korea Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12 Western Europe Market: 12.1 Summary; 12.2 Market Overview; 12.2.1 Region Information; 12.2.2 Market Information; 12.2.3 Background Information; 12.2.4 Government Initiatives; 12.2.5 Regulations; 12.2.6 Regulatory Bodies; 12.2.7 Major Associations; 12.2.8 Taxes Levied; 12.2.9 Corporate tax structure; 12.2.10 Investments; 12.2.11 Major Companies; 12.3 Western Europe Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.4 Western Europe Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.5 Western Europe Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.6 UK Market; 12.7 UK Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.8 UK Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.9 UK Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.10 Germany Market; 12.11 Germany Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.12 Germany Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.13 Germany Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.14 France Market; 12.15 France Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.16 France Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.17 France Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.18 Italy Market; 12.19 Italy Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.20 Italy Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.21 Italy Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.22 Spain Market; 12.23 Spain Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.24 Spain Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.25 Spain Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13 Eastern Europe Market: 13.1 Summary; 13.2 Market Overview; 13.2.1 Region Information; 13.2.2 Market Information; 13.2.3 Background Information; 13.2.4 Government Initiatives; 13.2.5 Regulations; 13.2.6 Regulatory Bodies; 13.2.7 Major Associations; 13.2.8 Taxes Levied; 13.2.9 Corporate Tax Structure; 13.2.10 Investments; 13.2.11 Major companies; 13.3 Eastern Europe Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 13.4 Eastern Europe Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 13.5 Eastern Europe Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 13.6 Russia Market; 13.7 Russia Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 13.8 Russia Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 13.9 Russia Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14 North America Market: 14.1 Summary; 14.2 Market Overview; 14.2.1 Region Information; 14.2.2 Market Information; 14.2.3 Background Information; 14.2.4 Government Initiatives; 14.2.5 Regulations; 14.2.6 Regulatory Bodies; 14.2.7 Major Associations; 14.2.8 Taxes Levied; 14.2.9 Corporate Tax Structure; 14.2.10 Investments; 14.2.11 Major Companies; 14.3 North America Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 14.4 North America Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 14.5 North America Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 14.6 USA Market; 14.7 Summary; 14.8 Market Overview; 14.8.1 Country Information; 14.8.2 Market Information; 14.8.3 Background Information; 14.8.4 Government Initiatives; 14.8.5 Regulations; 14.8.6 Regulatory Bodies; 14.8.7 Major Associations; 14.8.8 Taxes Levied; 14.8.9 Corporate Tax Structure; 14.8.10 Investments; 14.8.11 Major Companies; 14.9 USA Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 14.10 USA Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 14.11 USA Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 14.12 Canada Market; 14.13 Summary; 14.14 Market Overview; 14.14.1 Country Information; 14.14.2 Market Information; 14.14.3 Background Information; 14.14.4 Government Initiatives; 14.14.5 Regulations; 14.14.6 Regulatory Bodies; 14.14.7 Major Associations; 14.14.8 Taxes Levied; 14.14.9 Corporate Tax Structure; 14.14.10 Investments; 14.14.11 Major Companies; 14.15 Canada Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 14.16 Canada Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 14.17 Canada Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
15 South America Market: 15.1 Summary; 15.2 Market Overview; 15.2.1 Region Information; 15.2.2 Market Information; 15.2.3 Background Information; 15.2.4 Government Initiatives; 15.2.5 Regulations; 15.2.6 Regulatory Bodies; 15.2.7 Major Associations; 15.2.8 Taxes Levied; 15.2.9 Corporate Tax Structure; 15.2.10 Investments; 15.2.11 Major Companies; 15.3 South America Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 15.4 South America Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 15.5 South America Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 15.6 Brazil Market; 15.7 Brazil Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 15.8 Brazil Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 15.9 Brazil Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
16 Middle East Market: 16.1 Summary; 16.2 Market Overview; 16.2.1 Region Information; 16.2.2 Market Information; 16.2.3 Background Information; 16.2.4 Government Initiatives; 16.2.5 Regulations; 16.2.6 Regulatory Bodies; 16.2.7 Major Associations; 16.2.8 Taxes Levied; 16.2.9 Corporate Tax Structure; 16.2.10 Investments; 16.2.11 Major Companies; 16.3 Middle East Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 16.4 Middle East Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 16.5 Middle East Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
17 Africa Market: 17.1 Summary; 17.2 Market Overview; 17.2.1 Region Information; 17.2.2 Market Information; 17.2.3 Background Information; 17.2.4 Government Initiatives; 17.2.5 Regulations; 17.2.6 Regulatory Bodies; 17.2.7 Major Associations; 17.2.8 Taxes Levied; 17.2.9 Corporate Tax Structure; 17.2.10 Investments; 17.2.11 Major Companies; 17.3 Africa Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 17.4 Africa Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 17.5 Africa Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
18 Competitive Landscape And Company Profiles: 18.1 Company Profiles; 18.2 Bayer AG; 18.2.1 Company Overview; 18.2.2 Products And Services; 18.2.3 Business Strategy; 18.2.4 Financial Overview; 18.3 Johnson & Johnson; 18.3.1 Company Overview; 18.3.2 Products And Services; 18.3.3 Financial Overview; 18.4 GlaxoSmithKline PLC; 18.4.1 Company Overview; 18.4.2 Products And Services; 18.4.3 Financial Overview; 18.5 Reckitt Benckiser Group PLC; 18.5.1 Company Overview; 18.5.2 Products And Services; 18.5.3 Business Strategy; 18.5.4 Financial Overview; 18.6 Sanofi S.A.; 18.6.1 Company Overview; 18.6.2 Products And Services; 18.6.3 Financial Overview
19 Other Major And Innovative Companies: 19.1 Perrigo Company plc; 19.1.1 Company Overview; 19.1.2 Products And Services; 19.2 Haleon plc; 19.2.1 Company Overview; 19.2.2 Products And Services; 19.3 Teva Pharmaceutical Industries Ltd; 19.3.1 Company Overview; 19.3.2 Products And Services; 19.4 Dr. Reddy's Laboratories; 19.4.1 Company Overview; 19.4.2 Products And Services; 19.5 Cipla Ltd.; 19.5.1 Company Overview; 19.5.2 Products And Services; 19.6 Sun Pharmaceutical Industries Ltd; 19.6.1 Company Overview; 19.6.2 Products And Services; 19.7 Amneal Pharmaceuticals Inc.; 19.7.1 Company Overview; 19.7.2 products And Services; 19.8 Abbott Laboratories; 19.8.1 Company Overview; 19.8.2 Products And Services; 19.9 Boehringer Ingelheim International GmbH; 19.9.1 Company Overview; 19.9.2 Products And Services; 19.10 Glenmark Therapeutics Ltd.; 19.10.1 Company Overview; 19.10.2 Products And Services; 19.11 Alkem Laboratories Ltd.; 19.11.1 Company Overview; 19.11.2 Products And Services; 19.12 Sonoma Pharmaceuticals Inc.; 19.12.1 Company Overview; 19.12.2 Products And Services; 19.13 Takeda Pharmaceutical Company Ltd; 19.13.1 Company Overview; 19.13.2 Products And Services; 19.14 Viatris (Mylan NV); 19.14.1 Company Overview; 19.14.2 Products And Services; 19.15 AFT Pharmaceuticals Ltd.; 19.15.1 Company Overview; 19.15.2 Products And Services
20 Competitive Benchmarking
21 Competitive Dashboard
22 Key Mergers And Acquisitions: 22.1 Cooper Consumer Health Acquired Viatris Inc.; 22.2 Avista Healthcare Partners Acquired Trillium Healthcare Products; 22.3 Cipla South Africa Acquired Actor Pharma (Pty) Ltd.; 22.4 Glenmark Pharmaceuticals Inc. Acquired Wockhardt USA Inc.
23 Recent Developments in Over The Counter (OTC) Drugs: 23.1 New Over-the-Counter Laxative Targets Growing Constipation Demand; 23.2 Leveraging Big Data for Seamless Transition to Over-the-Counter Medications; 23.3 Enhancing Maternal Health and Infant Development with a New Over-the-Counter Supplement
24 Opportunities And Strategies: 24.1 Over The Counter (OTC) Drugs Market In 2029 – Countries Offering Most New Opportunities; 24.2 Over The Counter (OTC) Drugs Market In 2029 – Segments Offering Most New Opportunities; 24.3 Over The Counter (OTC) Drugs Market In 2029 – Growth Strategies; 24.3.1 Market Trend Based Strategies; 24.3.2 Competitor Strategies
25 Over The Counter (OTC) Drugs Market, Conclusions And Recommendations: 25.1 Conclusions; 25.2 Recommendations; 25.2.1 Product; 25.2.2 Place; 25.2.3 Price; 25.2.4 Promotion; 25.2.5 People
26 Appendix: 26.1.1 Geographies Covered; 26.1.2 Market Data Sources; 26.1.3 Research Methodology; 26.1.4 Currencies; 26.1.5 The Business Research Company; 26.1.6 Copyright and Disclaimer

Search Inside Report

Pricing

Currency Rates

Single User Online Download $4,490
Site License Online Download $6,490
Global Site License Online Download $8,490

How Do Licenses Work?

Request A Sample

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now